Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Novel Controlled Release Drug Delivery Systems by Applying 3D Printing Technology"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 2853
Special Issue Editors
Interests: pharmacokinetics; pharmacodynamics; modeling and simulation; 3D printing; controlled release formulations
Interests: pharmacokinetics; translational PKPD modeling; PBPK modeling; in vitro–in vivo correlation; pharmaceutical analysis; 3D printing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Since the first FDA approval of 3D printed tablet, there has been an emerging interest in the pharmaceutical application of 3D printing technology, or additive manufacturing. The unique advantages of 3D printing technology over conventional manufacturing have shown its potential to improve upon current pharmaceutical dosage forms through complex and customized dosage forms which are not cost-effective or otherwise impossible. In the last decades, therefore, 3D printing has been extensively explored and applied to design and develop innovative controlled release dosage forms.
In this Special Issue, we seek to highlight the advantages, key challenges, and future directions of the application of 3D printing technology for the development of novel controlled release drug delivery systems. Topics may include, but are not limited to, various innovative applications of 3D printing technology in controlled release dosage forms and drug delivery systems and their in vitro as well as in vivo evaluations. We look forward to your submission of original research work or review articles.
Prof. Soyoung Shin
Prof. Beom Soo Shin
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- 3D printing
- additive manufacturing
- controlled release
- oral dosage forms
- drug delivery system
- sustained release
- gastroretentive system
- in vitro test
- in vivo pharmacokinetics